Browsing Tag
Melbourne
52 posts
Qualitas lifts AI-backed margin target above 60% as ASX:QAL recovery accelerates
Qualitas Limited is moving artificial intelligence from employee productivity tools into core credit underwriting, targeting a higher-margin funds management platform without proportionately increasing headcount.
Avecho Biotechnology clears Phase III insomnia interim review as ASX:AVE surges 40%
Avecho Biotechnology’s CBD insomnia trial will continue with its original 519-patient design after an independent monitoring board found that predefined efficacy and safety requirements had been satisfied.
Alterity Therapeutics (ASX:ATH) has FDA clarity, but Phase 3 funding now tests the rally
Alterity has FDA clarity for ATH434. The bigger question is whether ASX:ATH can fund and execute Phase 3 without losing momentum.
Synertec (ASX: SOP) drops as Hitachi Energy collaboration excitement fades into post-update profit-taking
Synertec just signed Hitachi Energy. The Powerhouse is AI-powered grid tech. The market cap is A$12m. The analyst consensus target is 400% above current.
Tabcorp (ASX: TAH) collapse deepens as AUSTRAC compliance probe revives 2017 AML breach memories
Tabcorp paid A$45m for AML breaches in 2017. AUSTRAC just sent another letter. The market priced in the worst case before management could speak.
REA Group (ASX: REA) shares jump as Q3 FY2026 result lifts cost guidance and confirms residential recovery
REA Group fell 9.6% on H1 results in February. Today's Q3 print rewrites that thesis. Listing volumes are back, yield is at 14%, costs are being held.
Textron Inc. (NYSE: TXT) strengthens Asia-Pacific support with Essendon Fields expansion
APAC aircraft demand is rising faster than service capacity. Textron Aviation’s Melbourne bet could reshape regional support economics.
Pinnacle Investment Management (ASX: PNI) share price jumps 5% after Pacific Asset Management completion
Pinnacle just closed the $419m PAM deal and the stock bounced 5%. Affiliate FUM hits $202.5bn. Performance fees are the next test in July.
Persistent Systems (NSE: PERSISTENT) grows at five times Infosys’s guided pace in FY26 as AI deal wins accelerate
Persistent Systems posts $1.65B FY26 revenue with 17.4% growth and 15.6% EBIT margin. Read what the 24th consecutive growth quarter signals for Indian IT. →
Atomos (ASX: AMS) bets on new product cycle and NAB Show 2026 to lock in its turnaround
Atomos (ASX: AMS) returned to profit in H1 FY2026 with 28% revenue growth. Here is the retail investor roadmap for the next phase of its turnaround.